Philippines' Casino Filipino Privatization Could Cost Health Program Up to ₱2.1 Billion Annually

Health Funding at Stake

The planned privatization of Casino Filipino branches could drain between ₱1.7 billion and ₱2.1 billion annually from the Philippines' Universal Health Care program, according to an analysis released by Geronimo Law.

The Manila-based firm examined the fiscal impact of separating the commercial and regulatory functions of the Philippine Amusement and Gaming Corporation, which currently operates Casino Filipino under a legislative franchise running until July 2033. While the restructuring may address governance conflicts and trim operating expenses, it threatens a vital revenue channel for public health initiatives.

Under Republic Act 11223, the Universal Healthcare Law, half of PAGCOR's treasury remittances flow directly to the Philippine Health Insurance Corporation to expand equitable access to medical services. Casino Filipino delivered ₱3.02 billion to the UHC program in 2024 and ₱2.47 billion in 2025.

The Regulatory Shift

Once privatization proceeds, PAGCOR would abandon its operator role and function exclusively as a regulator collecting license fees from private casino owners. The firm's July 22 report highlights a fundamental arithmetic problem: "For UHC to be made whole through license fees alone, privatized branches would have to more than triple their gross gaming revenue."

PAGCOR chair Alejandro Tengco previously indicated that the Governance Commission for government-owned and controlled corporations will deliver its recommendation to the Office of the President during the third quarter of 2026, with an executive order anticipated by year-end. The sale of approximately 40 branches is scheduled to run from late 2026 through 2027, culminating in full decoupling by 2028.

Purchase Price Won't Fill the Gap

PAGCOR projects sale proceeds between ₱30 billion and ₱50 billion. Yet none of that windfall will reach UHC coffers. The healthcare earmark applies exclusively to ongoing gaming income, not one-time asset sales.

Geronimo Law quantified the recurring cost to universal health care at approximately ₱1.6 billion to ₱2.3 billion for every year following the sale. The firm acknowledged that privatization may carry merit on regulatory grounds, separating oversight from commercial interests, but emphasized the measurable fiscal consequence for public health financing.

The analysis surfaces a policy tension familiar across Southeast Asia: governments seeking to modernize state enterprise governance while preserving social welfare funding streams that evolved around those enterprises. Indonesia's restructuring of state lottery operations and Malaysia's debates over casino licensing have encountered similar trade-offs between regulatory clarity and revenue stability.

What Comes Next

The timeline points to concrete decisions within months. If the executive order materializes by year-end as Tengco suggested, the first branch sales could close before the second quarter of 2027. License fee structures and any compensatory funding mechanisms for UHC will need legislative or executive definition before the transition completes in 2028.

The ₱1.7-2.1 billion annual shortfall represents roughly 1.4 to 1.7 percent of PhilHealth's 2025 budget, a gap large enough to affect coverage breadth or benefit generosity if left unaddressed. Whether the administration opts to backfill the loss through general appropriations, adjust the license fee formula, or accept reduced health spending remains an open question as the Governance Commission finalizes its recommendation.